ASO Visual Abstract: Implications for Sentinel Lymph Node Biopsy Omission in Patients with Early Stage Node-Negative HR+/HER2- Breast Cancer Undergoing Mastectomy.
1/5 보강
OpenAlex 토픽 ·
Breast Cancer Treatment Studies
Cancer Risks and Factors
Advanced Breast Cancer Therapies
APA
Jennifer Chen, Kerollos Nashat Wanis, et al. (2026). ASO Visual Abstract: Implications for Sentinel Lymph Node Biopsy Omission in Patients with Early Stage Node-Negative HR+/HER2- Breast Cancer Undergoing Mastectomy.. Annals of surgical oncology. https://doi.org/10.1245/s10434-026-19661-7
MLA
Jennifer Chen, et al.. "ASO Visual Abstract: Implications for Sentinel Lymph Node Biopsy Omission in Patients with Early Stage Node-Negative HR+/HER2- Breast Cancer Undergoing Mastectomy.." Annals of surgical oncology, 2026.
PMID
42018250 ↗
같은 제1저자의 인용 많은 논문 (5)
- Primary tumor surgery in patients with de novo stage IV breast cancer: Is there an optimal subgroup for locoregional therapy?
- CCR7 immune cell receptor expression in inflammatory breast cancer.
- Implications for Sentinel Lymph Node Biopsy Omission in Patients with Early-Stage Node-Negative HR+/HER2- Breast Cancer Undergoing Mastectomy.
- Tumor Size as a Predictive Indicator for Lymph Node Metastasis in Papillary Thyroid Carcinoma: An Inverted L-Shaped Curve Analysis Based on the SEER Database.
- Combination Assay of Methylated HOXA1 with Tumor Markers for Detection of Early-Stage Hepatocellular Carcinoma.